id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-N-5471-4278,FDA,FDA-2024-N-5471,Request for Four-Month Extension of Comment Period from JTI LIGGETT LLC,Other,Request for Extension,2025-10-01T04:00:00Z,2025,10,2025-10-01T04:00:00Z,,2025-10-01T21:10:08Z,,0,0,09000064b8f1fda7
FDA-2024-N-5471-0935,FDA,FDA-2024-N-5471,TAB A - Nicotine PRIA as Submitted to OMB,Supporting & Related Material,Background Material,2025-01-17T05:00:00Z,2025,1,,,2025-06-06T20:24:40Z,,0,0,09000064868cd8a6
FDA-2024-N-5471-0936,FDA,FDA-2024-N-5471,TAB B - Nicotine NPRM Track Changes,Supporting & Related Material,Background Material,2025-01-17T05:00:00Z,2025,1,,,2025-06-06T20:24:40Z,,0,0,09000064868cd8a7
FDA-2024-N-5471-0938,FDA,FDA-2024-N-5471,TAB C - Nicotine NPRM as Cleared by OMB,Supporting & Related Material,Background Material,2025-01-17T05:00:00Z,2025,1,,,2025-06-06T20:24:40Z,,0,0,09000064868cddb8
FDA-2024-N-5471-0937,FDA,FDA-2024-N-5471,TAB B - Nicotine PRIA Track Changes,Supporting & Related Material,Background Material,2025-01-17T05:00:00Z,2025,1,,,2025-06-06T20:24:40Z,,0,0,09000064868cd8a8
FDA-2024-N-5471-0933,FDA,FDA-2024-N-5471,Memo to FDA DMB re Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products (Proposed Rule),Other,Memorandum,2025-01-17T05:00:00Z,2025,1,2025-01-17T05:00:00Z,,2025-06-06T20:24:40Z,,0,0,09000064868cd752
FDA-2024-N-5471-0934,FDA,FDA-2024-N-5471,TAB A - Nicotine NPRM as Submitted to OMB,Supporting & Related Material,Background Material,2025-01-17T05:00:00Z,2025,1,,,2025-06-06T20:24:40Z,,0,0,09000064868cd8a5
FDA-2024-N-5471-0939,FDA,FDA-2024-N-5471,TAB C - Nicotine PRIA as Cleared by OMB,Supporting & Related Material,Background Material,2025-01-17T05:00:00Z,2025,1,,,2025-06-06T20:24:40Z,,0,0,09000064868cddbe
FDA-2024-N-5471-0004,FDA,FDA-2024-N-5471,Reference 2 - Brown William Letter from RB Griffith 1963,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:16Z,,0,0,090000648689966a
FDA-2024-N-5471-0009,FDA,FDA-2024-N-5471,Reference 7 - FDA Hookah Tobacco Shisha or Waterpipe 2023,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:17Z,,0,0,090000648689966f
FDA-2024-N-5471-0013,FDA,FDA-2024-N-5471,Reference 11 - Max Deaths from secondhand smoke exposure 2012,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:17Z,,0,0,0900006486899bdd
FDA-2024-N-5471-0039,FDA,FDA-2024-N-5471,Reference 37 - Chaiton Estimating the number of quit 2016,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:18Z,,0,0,0900006486899cbf
FDA-2024-N-5471-0120,FDA,FDA-2024-N-5471,Reference 118 - Ellis Racial and Ethnic Disparities 2018,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:19Z,,0,0,0900006486899e36
FDA-2024-N-5471-0128,FDA,FDA-2024-N-5471,Reference 126 - Vurbic Cooccurring obesity and smoking 2015,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:19Z,,0,0,0900006486899e3e
FDA-2024-N-5471-0217,FDA,FDA-2024-N-5471,Reference 215 Chen Sankey Real Time Context of Tobacco 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:20Z,,0,0,090000648689a066
FDA-2024-N-5471-0056,FDA,FDA-2024-N-5471,Reference 54 - McDonald Deposition of cigar smoke particles 2002,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:21Z,,0,0,090000648689a14a
FDA-2024-N-5471-0066,FDA,FDA-2024-N-5471,Reference 64 - Donny Smoking in the absence of nicotine 2007,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:21Z,,0,0,090000648689a161
FDA-2024-N-5471-0088,FDA,FDA-2024-N-5471,Reference 86 - Substance Abuse Key substance use and mental 2024,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:22Z,,0,0,090000648689a177
FDA-2024-N-5471-0166,FDA,FDA-2024-N-5471,Reference 164 - Baker Health risks associated with cigar 2000,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:22Z,,0,0,090000648689a89d
FDA-2024-N-5471-0171,FDA,FDA-2024-N-5471,Reference 169 - Inoue Choi Contemporary Associations 2019,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:22Z,,0,0,090000648689a8a2
FDA-2024-N-5471-0185,FDA,FDA-2024-N-5471,Reference 183 - Primack Volume of tobacco advertising 2007,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:23Z,,0,0,090000648689a8b4
FDA-2024-N-5471-0199,FDA,FDA-2024-N-5471,Reference 197 - Apollonio Marketing to the marginalised 2005,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:23Z,,0,0,090000648689a8cc
FDA-2024-N-5471-0010,FDA,FDA-2024-N-5471,Reference 8 - National Academies Public health consequence 2018,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:17Z,,0,0,0900006486899bef
FDA-2024-N-5471-0016,FDA,FDA-2024-N-5471,Reference 14 - Mendez Monitoring the Increase in the U.S 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:17Z,,0,0,0900006486899ca5
FDA-2024-N-5471-0024,FDA,FDA-2024-N-5471,Reference 22 - Kann Youth risk behavior surveillance 2016,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:17Z,,0,0,0900006486899cad
FDA-2024-N-5471-0042,FDA,FDA-2024-N-5471,Reference 40 - Benowitz Nicotine and carcinogen exposure 2007,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:18Z,,0,0,0900006486899cc2
FDA-2024-N-5471-0094,FDA,FDA-2024-N-5471,Reference 92 - Sargent Adolescent smoking experimentation 2017,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:18Z,,0,0,0900006486899d95
FDA-2024-N-5471-0119,FDA,FDA-2024-N-5471,Reference 117 - Howe Indirect method to estimate specific 2009,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:19Z,,0,0,0900006486899e35
FDA-2024-N-5471-0125,FDA,FDA-2024-N-5471,Reference 123 - HHS Tobacco Use Among US Racial ethnic 1998,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:19Z,,0,0,0900006486899e3b
FDA-2024-N-5471-0131,FDA,FDA-2024-N-5471,Reference 129 - Stanton Trends in tobacco use among US 2016,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:19Z,,0,0,0900006486899e41
FDA-2024-N-5471-0153,FDA,FDA-2024-N-5471,Reference 151 - Arku Seasonal variability in environmental 2015,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:20Z,,0,0,0900006486899e5a
FDA-2024-N-5471-0207,FDA,FDA-2024-N-5471,Reference 205 Yerger What more evidence is needed 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:20Z,,0,0,090000648689a04f
FDA-2024-N-5471-0210,FDA,FDA-2024-N-5471,Reference 208 Gunther Presumed influence on peer norms 2006,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:20Z,,0,0,090000648689a052
FDA-2024-N-5471-0223,FDA,FDA-2024-N-5471,Reference 221 Nicksic Smoking status and racial ethnic 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:20Z,,0,0,090000648689a06c
FDA-2024-N-5471-0170,FDA,FDA-2024-N-5471,Reference 168 - Christensen Association of cigarette 2018,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:22Z,,0,0,090000648689a8a1
FDA-2024-N-5471-0172,FDA,FDA-2024-N-5471,Reference 170 - Eichner Tobacco use and cardiovascular 2010,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:22Z,,0,0,090000648689a8a3
FDA-2024-N-5471-0182,FDA,FDA-2024-N-5471,Reference 180 - Carroll Tobacco Industry Marketing Exposure 2020,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:23Z,,0,0,090000648689a8ad
FDA-2024-N-5471-0195,FDA,FDA-2024-N-5471,Reference 193 - Marsh Association between density 2021,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:23Z,,0,0,090000648689a8c8
FDA-2024-N-5471-0145,FDA,FDA-2024-N-5471,Reference 143 - Cochran Sexual orientation related 2013,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:19Z,,0,0,0900006486899e52
FDA-2024-N-5471-0226,FDA,FDA-2024-N-5471,Reference 224 Soneji Online tobacco marketing among US 2019,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:20Z,,0,0,090000648689a06f
FDA-2024-N-5471-0239,FDA,FDA-2024-N-5471,Reference 237 Kaufman Food and Drug Administration Evaluation 2011,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:21Z,,0,0,090000648689a07c
FDA-2024-N-5471-0247,FDA,FDA-2024-N-5471,Reference 245 Weiger Beliefs and Characteristics Associated 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:21Z,,0,0,090000648689a084
FDA-2024-N-5471-0057,FDA,FDA-2024-N-5471,Reference 55 - Rodriguez The association of pipe and 2010,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:21Z,,0,0,090000648689a14b
FDA-2024-N-5471-0067,FDA,FDA-2024-N-5471,Reference 65 - Walker Longitudinal examination of predictors 2014,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:21Z,,0,0,090000648689a162
FDA-2024-N-5471-0113,FDA,FDA-2024-N-5471,Reference 111 - Pulvers Light and intermittent smoking 2015,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:22Z,,0,0,090000648689a508
FDA-2024-N-5471-0164,FDA,FDA-2024-N-5471,Reference 162 - HHS Reducing the health consequences of 1989,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:22Z,,0,0,090000648689a89b
FDA-2024-N-5471-0450,FDA,FDA-2024-N-5471,Reference 448 - Rose Psychopharmacological interactions 2004,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:31Z,,0,0,090000648689d3d2
FDA-2024-N-5471-0642,FDA,FDA-2024-N-5471,Reference 640 Pappas Cadmium lead and thallium in smoke 2007,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:32Z,,0,0,090000648689d555
FDA-2024-N-5471-0613,FDA,FDA-2024-N-5471,Reference 611 Faulkner Neural basis of smoking induced 2019,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:32Z,,0,0,090000648689db17
FDA-2024-N-5471-0617,FDA,FDA-2024-N-5471,Reference 615 Parker Effect of brief nicotine corrective 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:33Z,,0,0,090000648689db1b
FDA-2024-N-5471-0621,FDA,FDA-2024-N-5471,Reference 619 Pacek Knowledge about nicotine among HIV 2017,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:33Z,,0,0,090000648689db1f
FDA-2024-N-5471-0629,FDA,FDA-2024-N-5471,Reference 627 Marshall Evaluation of smoking characteristics 2008,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:33Z,,0,0,090000648689db27
FDA-2024-N-5471-0712,FDA,FDA-2024-N-5471,PRIA Reference 43 National Center for Health Statistics Public Use Linked Mortality Files 2019,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:34Z,,0,0,09000064868a5b12
FDA-2024-N-5471-0724,FDA,FDA-2024-N-5471,PRIA Reference 55 US Department of Health and Human Services Eliminating Tobacco Related Disease and Death 2024,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:34Z,,0,0,09000064868a5b2c
FDA-2024-N-5471-0730,FDA,FDA-2024-N-5471,PRIA Reference 61 Thun Smoking vs Other Risk Factors as the Cause of Smoking Attributable Deaths 2000,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:35Z,,0,0,09000064868a5b32
FDA-2024-N-5471-0722,FDA,FDA-2024-N-5471,PRIA Reference 53 US Food and Drug Administration Tobacco User Fee Assessment Formulation by Product Class 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:34Z,,0,0,09000064868a5b2a
FDA-2024-N-5471-0740,FDA,FDA-2024-N-5471,PRIA Reference 71 Bolnick Health Care Spending Attributable to Modifiable Risk Factors 2020,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:35Z,,0,0,09000064868a5b3c
FDA-2024-N-5471-0763,FDA,FDA-2024-N-5471,PRIA Reference 94 Gong Whats in a butt environmental contamination 2017,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5f29
FDA-2024-N-5471-0768,FDA,FDA-2024-N-5471,PRIA Reference 99 Wu Smoking Cessation and Changes in Anxiety and Depression 2023,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5f2e
FDA-2024-N-5471-0781,FDA,FDA-2024-N-5471,PRIA Reference 112 RTI Reformulation Cost Model 2015,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5f99
FDA-2024-N-5471-0794,FDA,FDA-2024-N-5471,PRIA Reference 125 US Department of Health and Human Services Commonly Used Drugs Charts 2020,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5fa6
FDA-2024-N-5471-0823,FDA,FDA-2024-N-5471,PRIA Reference 154 Denlinger Apte Low Nicotine Content Descriptors Reduce Perceived Health Risks 2017,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:38Z,,0,0,09000064868a600b
FDA-2024-N-5471-0825,FDA,FDA-2024-N-5471,PRIA Reference 156 Perkins The Influence of Instructions and Nicotine Dose 2004,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:38Z,,0,0,09000064868a600d
FDA-2024-N-5471-0439,FDA,FDA-2024-N-5471,Reference 437 - Perkins Acute negative affect relief from 2010,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:31Z,,0,0,090000648689d3c7
FDA-2024-N-5471-0443,FDA,FDA-2024-N-5471,Reference 441 - Carter Principles of laboratory 2009,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:31Z,,0,0,090000648689d3cb
FDA-2024-N-5471-0842,FDA,FDA-2024-N-5471,PRIA Reference 173 Soneji Transitions in Frequency of Hookah Smoking 2021,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:35Z,,0,0,09000064868a5bbb
FDA-2024-N-5471-0696,FDA,FDA-2024-N-5471,PRIA Reference 27 - Shastri Disparities in Secondhand Smoke Exposure in the United States 2021,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:34Z,,0,0,09000064868a5b02
FDA-2024-N-5471-0703,FDA,FDA-2024-N-5471,PRIA Reference 34 - Jamal Tobacco Use Among Middle and High School Students 2017,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:34Z,,0,0,09000064868a5b09
FDA-2024-N-5471-0714,FDA,FDA-2024-N-5471,PRIA Reference 45 Euromonitor International Assessing the US Market for Cigars and Cigarillos 2021,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:34Z,,0,0,09000064868a5b22
FDA-2024-N-5471-0873,FDA,FDA-2024-N-5471,PRIA Reference 204 Lee Inequalities in Tobacco Outlet Density 2017,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:36Z,,0,0,09000064868a5c2d
FDA-2024-N-5471-0769,FDA,FDA-2024-N-5471,PRIA Reference 100 US Census Bureau Annual Capital Expenditures Survey 2024,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5f2f
FDA-2024-N-5471-0786,FDA,FDA-2024-N-5471,PRIA Reference 117 Piasecki Smoking Withdrawal Dynamics in Unaided Quitters 2000,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5f9e
FDA-2024-N-5471-0799,FDA,FDA-2024-N-5471,PRIA Reference 130 Kandel On the Development of Nicotine Dependence in Adolescence 2007,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5fab
FDA-2024-N-5471-0802,FDA,FDA-2024-N-5471,PRIA Reference 133 Substance Abuse and Mental Health Services Administration Key Substance Use and Mental Health Indicators 2020,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5fae
FDA-2024-N-5471-0810,FDA,FDA-2024-N-5471,PRIA Reference 141 Cawley The Demand for Cigarettes as Derived from the Demand for Weight Loss 2016,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:38Z,,0,0,09000064868a5fb6
FDA-2024-N-5471-0437,FDA,FDA-2024-N-5471,Reference 435 - Perkins Sex differences in the influence 2006,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:31Z,,0,0,090000648689d3c5
FDA-2024-N-5471-0444,FDA,FDA-2024-N-5471,Reference 442 - Cassidy Adolescent smokers response to 2018,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:31Z,,0,0,090000648689d3cc
FDA-2024-N-5471-0638,FDA,FDA-2024-N-5471,Reference 636 Lin Effect of menthol on nicotine reduction 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:32Z,,0,0,090000648689d551
FDA-2024-N-5471-0646,FDA,FDA-2024-N-5471,Reference 644 Creamer Tobacco Product Use and Cessation 2019,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:32Z,,0,0,090000648689d559
FDA-2024-N-5471-0607,FDA,FDA-2024-N-5471,Reference 605 Song Reduction and cessation of cigarette 2008,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:32Z,,0,0,090000648689db11
FDA-2024-N-5471-0877,FDA,FDA-2024-N-5471,PRIA Reference 208 Dsilva Tobacco Industry Misappropriation of American Indian Culture and Traditional Tobacco 2018,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:36Z,,0,0,09000064868a5c31
FDA-2024-N-5471-0886,FDA,FDA-2024-N-5471,PRIA Reference 217 Dai The Prevalence of Exposure to Workplace Secondhand Smoke 2017,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:36Z,,0,0,09000064868a5c3a
FDA-2024-N-5471-0758,FDA,FDA-2024-N-5471,PRIA Reference 89 Moerman Analysis of Metals Leached from Smoked Cigarette Litter 2011,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:36Z,,0,0,09000064868a5f24
FDA-2024-N-5471-0772,FDA,FDA-2024-N-5471,PRIA Reference 103 Davis Recessions and the Costs of Job Loss 2011,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5f32
FDA-2024-N-5471-0542,FDA,FDA-2024-N-5471,Reference 540 Chen Toxicological analysis of low 2008,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:29Z,,0,0,090000648689d0ba
FDA-2024-N-5471-0546,FDA,FDA-2024-N-5471,Reference 544 Doll Mortality from cancer in relation to 2005,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:29Z,,0,0,090000648689d0be
FDA-2024-N-5471-0547,FDA,FDA-2024-N-5471,Reference 545 National Center Public Use Linked Mortality 2019,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:29Z,,0,0,090000648689d0bf
FDA-2024-N-5471-0557,FDA,FDA-2024-N-5471,Reference 555 Jacobsen Effects of smoking and smoking 2005,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:30Z,,0,0,090000648689d0c9
FDA-2024-N-5471-0567,FDA,FDA-2024-N-5471,Reference 565 Jia Trends in quality adjusted life years 2010,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:30Z,,0,0,090000648689d0d3
FDA-2024-N-5471-0570,FDA,FDA-2024-N-5471,Reference 568 World Health Organization Tobacco Health Benefits 2020,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:30Z,,0,0,090000648689d0d6
FDA-2024-N-5471-0453,FDA,FDA-2024-N-5471,Reference 451 - Darredeau The effects of nicotine content 2013,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:31Z,,0,0,090000648689d3d5
FDA-2024-N-5471-0611,FDA,FDA-2024-N-5471,Reference 609 White Early Changes in Puffing Intensity 2022,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:32Z,,0,0,090000648689db15
FDA-2024-N-5471-0640,FDA,FDA-2024-N-5471,Reference 638 Pacek Evaluation of a reduced nicotine 2016,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:32Z,,0,0,090000648689d553
FDA-2024-N-5471-0623,FDA,FDA-2024-N-5471,Reference 621 Cassidy Age Moderates Smokers Subjective 2018,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:33Z,,0,0,090000648689db21
FDA-2024-N-5471-0676,FDA,FDA-2024-N-5471,PRIA Reference 7 US Department of Health and Human Services The Health Consequences of Smoking Nicotine Addiction 1988,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:33Z,,0,0,09000064868a5ad6
FDA-2024-N-5471-0680,FDA,FDA-2024-N-5471,PRIA Reference 11 - Hatsukami Reduced nicotine content cigarettes effects on toxicant exposure 2010,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:33Z,,0,0,09000064868a5ada
FDA-2024-N-5471-0685,FDA,FDA-2024-N-5471,PRIA Reference 16 - Gruber Is Addictional Rational 2001,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:34Z,,0,0,09000064868a5adf
FDA-2024-N-5471-0852,FDA,FDA-2024-N-5471,PRIA Reference 183 Safford Association of Race and Sex with Risk of Incident Acute Coronary Heart Disease 2012,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:35Z,,0,0,09000064868a5bc5
FDA-2024-N-5471-0878,FDA,FDA-2024-N-5471,PRIA Reference 209 National Cancer Institute The Role of the Media in Promoting and Reducing Tobacco Use 2008,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:36Z,,0,0,09000064868a5c32
FDA-2024-N-5471-0780,FDA,FDA-2024-N-5471,PRIA Reference 111 Just Welfare Economics of Public Policy 2004,Supporting & Related Material,Background Material,2025-01-16T05:00:00Z,2025,1,,,2025-06-06T20:24:37Z,,0,0,09000064868a5f98